May 7, 2020 Price forecast | 2 weeks: 3.55% | 1 month: 2.76% | 3 months: -0.48%

HBIO stock forecast

Our latest prediction for Harvard Bioscience, Inc.'s stock price was made on the May 7, 2020 when the stock price was at 2.53$.

In the short term (2weeks), HBIO's stock price should outperform the market by 3.55%. During that period the price should oscillate between -7.59% and +13.17%.

In the medium term (3months), HBIO's stock price should underperform the market by -0.48%. During that period the price should oscillate between -24.31% and +32.64%.

Create a solid portfolio with HBIO

Add HBIO to your portfolio and optimize it!

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

At the moment the company generates 116M USD in revenues.

On its last earning announcement, the company reported a loss of -0.12$ per share.

The book value per share is 2.11$

Harvard Bioscience, Inc. website

Three months stock forecastMay 7, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
116M 55.40% 2M 1.60% -5M -0.12 - - 38M 2.11 8M -1M 7M